The official page of the University of Colorado Anschutz Cancer Center - Colorado's only National Cancer Institute-designated cancer center.
Located on the Anschutz Medical Campus, the University of Colorado Cancer Center is Colorado’s only National Cancer Institute-designated comprehensive cancer center, a distinction recognizing its outstanding contributions to research, clinical trials, prevention and cancer control. CU Cancer Center is a member of the prestigious National Comprehensive Cancer Network®, an alliance of the nation’s leading cancer centers working to establish and deliver the gold standard in cancer clinical guidelines. NCI website: http://www.cancer.gov
National Comprehensive Cancer Network Website: http://www.nccn.org
03/01/2026
With today being Rare Disease Day, it's a good reminder that 5% to 10% of cancers can be linked to inherited genetic mutations.
Genetic counselor Michelle Springer, MS, CGC, shares her knowledge on the relationship of our genetics to cancer risk and genetic testing ⬇️
Inherited genetic mutations that can cause cancer are mostly rare, but they can greatly increase cancer risk, says a certified genetic counselor.
02/27/2026
Our partners at the CSU Animal Cancer Center had a unique opportunity this week, as they were part of the team that removed a cancerous mass from the tail of Emmett, a grizzly bear who resides in the Cheyenne Mountain Zoo. We are wishing a healthy and speedy recovery to Emmett! 🐻💛
02/27/2026
Cancer center researchers, such as Lindsey Davis, MD, are conducting clinical trials on one of the rarest cancers.
For Gallbladder and Bile Duct Cancer Awareness Month, learn about the clinical trials happening at the CU Anschutz Cancer Center that look to better treat bile duct cancer ⬇️
Clinical trials of perioperative chemotherapy and targeted therapy drugs at CU Anschutz Cancer Center offer new hope to bile duct cancer patients.
02/26/2026
We are excited to celebrate our cancer center members recognized at the 2026 CU Anschutz Research Awards Ceremony! 🎉
The ceremony honored faculty, staff, and trainees whose work elevated research at the University of Colorado Anschutz and strengthened the broader scientific community. With more than 250 nominations across nine categories, the event highlighted the remarkable talent and dedication across our campus.
Thank you to everyone who joined us in person or virtually to recognize this year’s outstanding awardees! 👏
02/26/2026
Co-leader of the cancer center’s Cancer Prevention and Control research program, Stacy Fischer, MD, talks about helping lead the largest US clinical trial on psilocybin use for anxiety in advanced cancer patients on this Science Friday episode.
Listen or read the transcript to this episode here ⬇️
How are the first state-run psilocybin therapy programs going? Plus, psilocybin clinical trials for cancer patients dealing with anxiety.
02/25/2026
Pafolacianine, also known as CYTALUX, is a new tool for doctors to detect cancer cells by fluorescently marking them.
Cancer center's Robert Meguid, MD, MPH, FACS, shares his thoughts on its effectiveness with Denver7 ⬇️
Surgeons at UCHealth Anschutz Cancer Pavilion in Aurora are using new technology to identify cancer cells they normally would have missed.
02/24/2026
Join us in welcoming Alice Soragni, PhD, to CU! 👋
As a nationally recognized leader in patient-derived tumor organoids and functional precision oncology, Soragni plans to launch a new initiative to identify promising treatments for patients with the most challenging-to-treat solid tumors ⬇️
National leader in tumor organoids Alice Soragni, PhD, launches a rapid functional precision medicine initiative at CU Anschutz within CCPM and DBMI.
02/24/2026
On her TikTok, Nicole “Snooki” Polizzi shared she has been diagnosed with Stage 1 cervical cancer after a cone biopsy following abnormal Pap smears. Her doctors say since it was caught early, it’s curable.
Snooki’s story emphasizes early detection and prevention, including not putting off doctor visits and the HPV vaccine. Learn more about cervical cancer here: https://bit.ly/4acc3CQ
02/20/2026
The U.S. Food and Drug Administration is speeding up its review of the drug daraxonrasib to determine whether it may deliver better results for pancreatic cancer patients.
Read this Q&A with cancer center leader Christopher Lieu, MD, to learn more about this targeted drug therapy ⬇️
The FDA is accelerating its review of a drug called daraxonrasib, which may be a more effective pancreatic cancer treatment, explains Christopher Lieu, MD.
02/19/2026
Don't mind us! We're just pointing out the sights, sounds, and geese on University of Colorado Anschutz. ☝️
02/18/2026
Until mid-March, board-certified physicians and registered Doximity members are eligible to vote in the U.S. News & World Report hospital rankings! 🏥 ✅
Be the first to know and let us send you an email when University of Colorado Anschutz Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Located on the Anschutz Medical Campus, the University of Colorado Cancer Center is Colorado’s only National Cancer Institute-designated comprehensive cancer center, a distinction recognizing its outstanding contributions to research, clinical trials, prevention and cancer control. CU Cancer Center is a member of the prestigious National Comprehensive Cancer Network®, an alliance of the nation’s leading cancer centers working to establish and deliver the gold standard in cancer clinical guidelines. CU Cancer Center is a consortium of more than 400 researchers and physicians at three state universities and six institutions, all working toward one goal: Translating science into life.
Mission
To discover, develop and deliver breakthroughs in diagnosis, treatment, and prevention that improve cancer care locally, nationally and globally. These efforts form the basis of a comprehensive spectrum of translational prevention, diagnosis, treatment, survivorship and outreach programs and provide a framework for training the next generation of cancer researchers and physicians.
Vision
To transform cancer research and practice in the state of Colorado by creating an integrated interdisciplinary nexus of clinicians and scientists across our statewide consortium that can leverage, synergize, marshal and focus resources and expertise to discover new ways to prevent and treat cancer.
NCI website: http://www.cancer.gov
National Comprehensive Cancer Network Website: http://www.nccn.org
